Safety of hydroxyurea in pregnancy: a systematic review of the literature. (avab uue akna)

Al Sulaimani R, Zitoun N, Alothman H, Hutson JR, Garcia-Bournissen F

Allikas‎: J Obstet Gynaecol Can. 2025 Jul;47(7):102924.

Indekseeritud‎: PubMed 40381805

DOI‎: 10.1016/j.jogc.2025.102924

https://pubmed.ncbi.nlm.nih.gov/40381805/ (avab uue akna)

Outcomes of pregnancies in sickle cell patients treated with hydroxyurea : findings from the escort-HU cohort studies. (avab uue akna)

Anoosha Habibi, Maryse Etienne-Julan, Maria Dimopoulou, Gylna Loko, Pagona Flevari, Narcisse Elenga, Sylvain LE Jeune, Estelle Jean, Laura Thomas-Bourgneuf, Jean-Benoit Arlet, Stephanie NGO, Emmanuelle Bernit, Corinne Charneau, Justine Dautremer, Laure Joseph, Giovanna Cannas, Pablo Bartolucci

Allikas‎: Blood 2025;146(Suppl 1):2-3.

Indekseeritud‎: DOI

DOI‎: 10.1182/blood-2025-2

https://ashpublications.org/blood/article/146/Supplement%201/2/553643/Outcomes-of-pregnancies-in-sickle-cell-patients (avab uue akna)

Systematic review: hydroxyurea for the treatment of adults with sickle cell disease. (avab uue akna)

Lanzkron S, Strouse JJ, Wilson R, Beach MC, Haywood C, Park H, Witkop C, Bass EB, Segal JB.

Allikas‎: Ann Intern Med 2008;148(12):939-55.

Indekseeritud‎: PubMed 18458272

https://www.ncbi.nlm.nih.gov/pubmed/18458272 (avab uue akna)

Cost-effectiveness of hydroxyurea in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. (avab uue akna)

Moore RD, Charache S, Terrin ML, Barton FB, Ballas SK.

Allikas‎: Am J Hematol 2000;64(1):26-31.

Indekseeritud‎: PubMed 10815784

https://www.ncbi.nlm.nih.gov/pubmed/10815784 (avab uue akna)

Hydroxyurea for the treatment of sickle cell anemia. (avab uue akna)

Platt OS.

Allikas‎: N Engl J Med 2008;358(13):1362-9.

Indekseeritud‎: PubMed 18367739

DOI‎: 10.1056/NEJMct0708272

https://www.ncbi.nlm.nih.gov/pubmed/18367739 (avab uue akna)

Clinical effectiveness of decitabine in severe sickle cell disease. (avab uue akna)

Saunthararajah Y, Molokie R, Saraf S, Sidhwani S, Gowhari M, Vara S, Lavelle D, DeSimone J.

Allikas‎: Br J Haematol 2008;141(1):126-9.

Indekseeritud‎: PubMed 18324975

DOI‎: 10.1111/j.1365-2141.2008.07027.x

https://www.ncbi.nlm.nih.gov/pubmed/18324975 (avab uue akna)

The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS). (avab uue akna)

Voskaridou E, Christoulas D, Bilalis A, Plata E, Varvagiannis K, Stamatopoulos G, Sinopoulou K, Balassopoulou A, Loukopoulos D, Terpos E.

Allikas‎: Blood 2010;115(12):2354-63.

Indekseeritud‎: PubMed 19903897

DOI‎: 10.1182/blood-2009-05-221333

https://www.ncbi.nlm.nih.gov/pubmed/19903897 (avab uue akna)

Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease. (avab uue akna)

Hirst C, Owusu-Ofori S.

Allikas‎: Cochrane Database Syst Rev 2012;(9):CD003427.

Indekseeritud‎: PubMed 22972063

DOI‎: 10.1002/14651858.CD003427.pub2

https://www.ncbi.nlm.nih.gov/pubmed/22972063 (avab uue akna)

Sickle cell disease. (avab uue akna)

Meremikwu MM, Okomo U.

Allikas‎: BMJ Clin Evid 2011;02:2402.

Indekseeritud‎: PubMed 21718552

https://www.ncbi.nlm.nih.gov/pubmed/21718552 (avab uue akna)

A phase 3 trial of l-glutamine in sickle cell disease. (avab uue akna)

Niihara Y, Miller ST, Kanter J, Lanzkron S, Smith WR, Hsu LL, Gordeuk VR, Viswanathan K, Sarnaik S, Osunkwo I, Guillaume E, Sadanandan S, Sieger L, Lasky JL, Panosyan EH, Blake OA, New TN, Bellevue R, Tran LT, Razon RL, Stark CW, Neumayr LD, Vichinsky EP

Allikas‎: N Engl J Med 2018;379(3):226-35.

Indekseeritud‎: PubMed 30021096

DOI‎: 10.1056/NEJMoa1715971

https://www.ncbi.nlm.nih.gov/pubmed/30021096 (avab uue akna)

Malaria chemoprophylaxis in sickle cell disease. (avab uue akna)

Oniyangi O, Omari AA.

Allikas‎: Cochrane Database Syst Rev 2006;(4):CD003489.

Indekseeritud‎: PubMed 17054173

DOI‎: 10.1002/14651858.CD003489.pub2

https://www.ncbi.nlm.nih.gov/pubmed/17054173 (avab uue akna)